Best General Drug Manufacturer Stocks to Buy Now (2025)Top general drug manufacturer stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best general drug manufacturer stocks to buy now. Learn More.
Industry: Drug Manufacturers - Gene...
A
General Drug Manufacturers is Zen Rated A and is the 6th ranked industry out of 145 stock market industries
Learn how the Zen Ratings work| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NVS | NOVARTIS AG | $234.04B | $53.22B | $26.42B | $12.86B | $6.44 | 11.50% | 1.29% | -12.62% | 3.93% | 2025-07-17 | ||
| JNJ | JOHNSON & JOHNSON | $377.99B | $89.33B | $34.70B | $21.81B | $9.06 | 4.30% | 1.55% | -40.63% | 6.83% | 2025-07-16 | ||
| GRFS | GRIFOLS SA | $6.10B | $8.01B | $1.71B | $174.36M | $0.26 | 2.57% | 5.57% | 258.21% | -25.16% | |||
| ABBV | ABBVIE INC | $337.52B | $57.37B | $14.30B | $4.20B | $2.36 | 5.45% | 10.99% | -29.97% | -16.08% | 2025-07-23 | ||
| AZN | ASTRAZENECA PLC | $230.70B | $68.50B | $17.68B | $7.77B | $2.51 | 13.70% | 22.09% | 22.49% | 34.22% | |||
| AMGN | AMGEN INC | $158.74B | $34.13B | $15.28B | $5.93B | $11.05 | 15.56% | 7.32% | 56.96% | -2.97% | 2025-08-04 | ||
| GSK | GSK PLC | $83.52B | $41.49B | $6.16B | $4.15B | $2.03 | 3.90% | -0.93% | -29.12% | -9.52% | 2025-07-29 | ||
| BMY | BRISTOL MYERS SQUIBB CO | $101.25B | $47.64B | $14.17B | $5.42B | $2.68 | 4.62% | 8.97% | N/A | 33.17% | 2025-07-31 | ||
| LLY | ELI LILLY & CO | $776.54B | $49.00B | $15.43B | $11.11B | $12.34 | 36.38% | 16.24% | 80.94% | 15.25% | |||
| GILD | GILEAD SCIENCES INC | $136.81B | $28.74B | $10.58B | $5.97B | $4.77 | 4.68% | 4.81% | 1,092.50% | 4.06% | |||
| MRK | MERCK & CO INC | $205.18B | $63.92B | $26.05B | $17.43B | $6.89 | 4.10% | 9.63% | 657.14% | 11.60% | 2025-07-29 | ||
| BIIB | BIOGEN INC | $19.14B | $9.82B | $2.52B | $1.48B | $10.16 | 1.59% | -7.41% | 26.21% | -20.72% | 2025-07-30 | ||
| PFE | PFIZER INC | $139.52B | $62.46B | $14.27B | $7.88B | $1.39 | 11.65% | 10.53% | N/A | -13.01% | 2025-07-28 | ||
| SNY | SANOFI | $125.48B | $46.13B | $11.90B | $5.79B | $2.31 | -0.24% | 1.76% | -3.38% | 13.35% | 2025-07-23 | ||
| OGN | ORGANON & CO | $2.61B | $6.29B | $1.48B | $750.00M | $2.91 | -0.84% | N/A | -29.02% | N/A | |||
| SCLX | SCILEX HOLDING CO | $33.51M | $50.71M | -$65.87M | -$74.51M | -$14.16 | 7.79% | N/A | N/A | N/A | |||
| AMRN | AMARIN CORP PLC | $274.37M | $214.11M | -$78.68M | -$87.93M | -$4.40 | -22.83% | -15.98% | N/A | N/A | |||
| MIRA | MIRA PHARMACEUTICALS INC | $20.47M | $0.00 | -$8.03M | -$7.92M | -$0.51 | N/A | N/A | N/A | N/A |
General Drug Manufacturer Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.